Asset Details
Do you wish to reserve the book?
Saudi experts’ recommendation for RSV prophylaxis in the era of COVID-19
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Saudi experts’ recommendation for RSV prophylaxis in the era of COVID-19
Do you wish to request the book?
Saudi experts’ recommendation for RSV prophylaxis in the era of COVID-19
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Saudi experts’ recommendation for RSV prophylaxis in the era of COVID-19
2021
Overview
Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis and viral pneumonia in pediatrics worldwide. In the Kingdom of Saudi Arabia (KSA), the prevalence of RSV is 23.5% in pediatric patients with acute lower respiratory tract illness. Coronavirus disease (COVID-19) poses critical public health and socioeconomic challenges in KSA. The Saudi Pediatric Pulmonology Association (SPPA), a subsidiary of the Saudi Thoracic Society (STS), developed a task force to determine the potential challenges and barriers to the RSV immunoprophylaxis program during the era of COVID-19 and to compose a practical, nationwide, and multidisciplinary approach to address these challenges. Some of the recommendations to manage these challenges include increasing the number of RSV immunoprophylaxis clinics, drive-thru visits, home-care services, and swift referrals to the RSV immunoprophylaxis program specialists. Additional training is required for healthcare personnel to add RSV immunoprophylaxis to the regular immunization schedule.
Publisher
Saudi Medical Journal
Subject
/ Antiviral Agents - therapeutic use
/ Bronchiolitis, Viral - prevention & control
/ Clinical Practice Guidelines
/ COVID-19 - prevention & control
/ Delivery of Health Care - methods
/ Humans
/ Immunization Programs - methods
/ Infant
/ Palivizumab - therapeutic use
/ Pediatric respiratory diseases
/ Respiratory syncytial virus infection
/ Respiratory Syncytial Virus Infections - prevention & control
